TAK-475

TAK-475

Stock Code: 3575909
Manufacturer Part No: SML2168-5MG
Order Now for 7 day delivery
£208.93 (exc VAT) per 5MG
Quantity: - +

Application


TAK-475 has been used:as a farnesyl-diphosphate farnesyltransferase 1 (FDFT1) inhibitor to study its effects on cell signaling in pancreatic ductal adenocarcinoma cellsas a squalene synthase (SQS) inhibitor to stabilize HMG-CoA reductase (HMGCR)-dCat-ELuc proteinsas an SQS inhibitor to study its effects on the migration of prostate cancer cells


Biochem/physiol Actions


TAK-475 (Lapaquistat acetate) is a potent and selective squalene synthase inhibitor. TAK-475 effectively lowers low-density lipoprotein cholesterol in human. Clinical development of TAK-475 was discontinued due to hepatotoxicity seen in two patients receiving a high dose.

Colourwhite to beige
InChI keyCMLUGNQVANVZHY-POURPWNDSA-N
InChI1S/C33H41ClN2O9/c1-20(37)44-19-33(2,3)18-36-25-10-9-22(34)16-24(25)30(23-7-6-8-26(42-4)31(23)43-5)45-27(32(36)41)17-28(38)35-13-11-21(12-14-35)15-29(39)40/h6-1
ManufacturerSIGMA-ALDRICH
Storage Temp.−20°C
SolubilityDMSO: 2 mg/mL, clear
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.